Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 254-273 d 865
-
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
(American Society of Clinical Oncology, 2024-01) -
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
(Nature Research, 2021-11-01) -
Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis
(Nature Research, 2020-07-08) -
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial
(American Medical Association, 2021-04) -
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability
(AME Publishing, 2023-12-26) -
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
(American Society of Clinical Oncology, 2022-10-01) -
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
(American Society of Hematology, 2023-01-12) -
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
(American Society of Clinical Oncology, 2021-02-01) -
Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer
(SAGE Publications, 2022-07-04) -
Engaging European society at the forefront of cancer research and care
(Wiley, 2023-06)